Compare HOG & PBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HOG | PBH |
|---|---|---|
| Founded | 1903 | 1996 |
| Country | United States | United States |
| Employees | 6400 | N/A |
| Industry | Motor Vehicles | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 3.3B |
| IPO Year | 1994 | 2004 |
| Metric | HOG | PBH |
|---|---|---|
| Price | $17.96 | $62.00 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 4 |
| Target Price | $24.88 | ★ $80.75 |
| AVG Volume (30 Days) | ★ 3.6M | 358.7K |
| Earning Date | 05-13-2026 | 05-07-2026 |
| Dividend Yield | ★ 3.96% | N/A |
| EPS Growth | N/A | ★ 2.88 |
| EPS | 2.78 | 2.78 |
| Revenue | ★ $4,473,175,000.00 | $975,777,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $3.53 | $2.15 |
| P/E Ratio | ★ $6.54 | $23.33 |
| Revenue Growth | N/A | ★ 36.77 |
| 52 Week Low | $17.11 | $57.25 |
| 52 Week High | $31.25 | $88.55 |
| Indicator | HOG | PBH |
|---|---|---|
| Relative Strength Index (RSI) | 36.02 | 30.65 |
| Support Level | $17.11 | $60.75 |
| Resistance Level | $19.63 | $63.26 |
| Average True Range (ATR) | 0.80 | 1.81 |
| MACD | -0.04 | -0.82 |
| Stochastic Oscillator | 26.16 | 0.11 |
Harley-Davidson is a leading global manufacturer of heavyweight motorcycles across the custom, cruising, and touring categories, as well as related merchandise, parts, and accessories. In recent years, the firm has expanded into the adventure touring market with its Pan America model and into electric with the LiveWire brand. Its captive finance arm, Harley-Davidson Financial Services, provides wholesale financing to dealers and retail financing and insurance brokerage services to customers. Harley captured around 34% of the heavyweight domestic market in 2025.
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.